Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Dustin B. Hammers, Ralitsa Kostadinova, Frederick W. Unverzagt & Liana G. Apostolova. (2022) Assessing and validating reliable change across ADNI protocols. Journal of Clinical and Experimental Neuropsychology 44:2, pages 85-102.
Read now
Read now
January Durant, Kevin Duff & Justin B. Miller. (2019) Regression-based formulas for predicting change in memory test scores in healthy older adults: Comparing use of raw versus standardized scores. Journal of Clinical and Experimental Neuropsychology 41:5, pages 460-468.
Read now
Read now
Kevin Duff, Kayla R. Suhrie, Bonnie C.A. Dalley, Jeffrey S. Anderson & John M. Hoffman. (2019) External validation of change formulae in neuropsychology with neuroimaging biomarkers: A methodological recommendation and preliminary clinical data. The Clinical Neuropsychologist 33:3, pages 478-489.
Read now
Read now
Ryosuke Kitahata, Shinichiro Nakajima, Hiroyuki Uchida, Tetsu Hayashida, Maiko Takahashi, Shintaro Nio, Jinichi Hirano, Maki Nagaoka, Takefumi Suzuki, Hiromitsu Jinno, Yuko Kitagawa & Masaru Mimura. (2017) Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study. Neuropsychiatric Disease and Treatment 13, pages 2489-2496.
Read now
Read now
Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles & Gary R. Morrow. (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry 26:1, pages 102-113.
Read now
Read now
Aude Caplette-Gingras, Josée Savard, Marie-Hélène Savard & Hans Ivers. (2013) Is Insomnia Associated With Cognitive Impairments in Breast Cancer Patients?. Behavioral Sleep Medicine 11:4, pages 239-257.
Read now
Read now
Barbara Collins, Joyce Mackenzie & Catherine Kyeremanteng. (2013) Study of the cognitive effects of chemotherapy: Considerations in selection of a control group. Journal of Clinical and Experimental Neuropsychology 35:4, pages 435-444.
Read now
Read now
Philip
G. Gasquoine. (2011) Cognitive impairment in common, noncentral nervous system medical conditions of adults and the elderly. Journal of Clinical and Experimental Neuropsychology 33:4, pages 486-496.
Read now
Read now
Karin Gehring, Neil K Aaronson, Martin J Taphoorn & Margriet M Sitskoorn. (2010) Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Review of Anticancer Therapy 10:11, pages 1779-1795.
Read now
Read now
Articles from other publishers (51)
Shelli R. Kesler, Ashley M. Henneghan, Sarah Prinsloo, Oxana Palesh & Max Wintermark. (2023) Neuroimaging based biotypes for precision diagnosis and prognosis in cancer-related cognitive impairment. Frontiers in Medicine 10.
Crossref
Crossref
Ekin Guran, Jian Hu, Jeffrey S. Wefel, Caroline Chung & Juan P. Cata. (2022) Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review. British Journal of Anaesthesia 129:6, pages 909-922.
Crossref
Crossref
Yongkai Lu, Xiaoqin Luo, Di Yang, Yi Li, Tuotuo Gong, Binglin Li, Jian Cheng, Ruijuan Chen, Xin Guo & Wei Yuan. (2022) Effects of probiotic supplementation on related side effects after chemoradiotherapy in cancer patients. Frontiers in Oncology 12.
Crossref
Crossref
Marciana-Nona Duma. (2022) Vorhersage kognitiver Beeinträchtigungen nach Chemotherapie bei Brustkrebs. InFo Hämatologie + Onkologie 25:9, pages 33-34.
Crossref
Crossref
Marciana-Nona Duma. (2022) Chemotherapiebedingte kognitive Beeinträchtigungen bei Mammakarzinompatientinnen – Risikofaktoren und TherapieChemotherapy-induced cognitive impairment in breast cancer patients—risk factors and therapy. Strahlentherapie und Onkologie 198:7, pages 667-669.
Crossref
Crossref
Cecilie R. Buskbjerg, Ali Amidi, Simon Buus, Claus H. Gravholt, S. M. Hadi Hosseini & Robert Zachariae. (2021) Androgen deprivation therapy and cognitive decline—associations with brain connectomes, endocrine status, and risk genotypes. Prostate Cancer and Prostatic Diseases 25:2, pages 208-218.
Crossref
Crossref
Michelle C Janelsins, Mostafa Mohamed, Luke J Peppone, Allison Magnuson, Elizabeth K Belcher, Marianne Melnik, Shaker Dakhil, Jodi Geer, Charles Kamen, Lori Minasian, Patrick M Reagan, Supriya G Mohile, Gary R Morrow, Tim A Ahles & Charles E Heckler. (2022) Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy. JNCI: Journal of the National Cancer Institute 114:1, pages 47-59.
Crossref
Crossref
Zhang Juan, Jie Chen, Boni Ding, Liang Yongping, Kai Liu, Ling Wang, Yuan Le, Qin Liao, Jingcheng Shi, Jufang Huang, Yuhui Wu, Daqing Ma, Wen Ouyang & Jianbin Tong. (2022) Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial. European Journal of Cancer 161, pages 10-22.
Crossref
Crossref
Maude Lambert, Amanda Wurz, Andra M. Smith, Zhuo Fang & Jennifer Brunet. (2021) Preliminary Evidence of Improvement in Adolescent and Young Adult Cancer Survivors’ Brain Health Following Physical Activity: A Proof-of-Concept Sub-Study. Brain Plasticity 7:2, pages 97-109.
Crossref
Crossref
Cecilie R. Buskbjerg, Ali Amidi, Mads Agerbaek, Claus H. Gravholt, SM Hadi Hosseini & Robert Zachariae. (2021) Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients–A prospective controlled study. Cancer Medicine 10:18, pages 6249-6260.
Crossref
Crossref
Nicoletta De Rosa, Luigi Della Corte, Alessia Giannattasio, Pierluigi Giampaolino, Costantino Di Carlo & Giuseppe Bifulco. (2021) Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study. Archives of Gynecology and Obstetrics 303:6, pages 1581-1588.
Crossref
Crossref
Karine A. Al Feghali, Mariana E. Bradshaw, Caroline Chung & Jeffrey S. Wefel. 2020. Central Nervous System Metastases. Central Nervous System Metastases
407
425
.
Karine A. Al Feghali, Caroline Chung, Jeffrey S. Wefel & Mariana E. Bradshaw. 2020. Central Nervous System Metastases. Central Nervous System Metastases
315
328
.
Rebecca M. Jones & Siobhan S. Pattwell. (2019) Future considerations for pediatric cancer survivorship: Translational perspectives from developmental neuroscience. Developmental Cognitive Neuroscience 38, pages 100657.
Crossref
Crossref
Stacy W. Hill. 2019. Neurosurgical Neuropsychology. Neurosurgical Neuropsychology
39
61
.
Michelle C. JanelsinsCharles E. HecklerLuke J. PepponeTim A. AhlesSupriya G. MohileKaren M. MustianOxana PaleshAnn M. O’MaraLori M. MinasianAnnalynn M. WilliamsAllison MagnusonJodi GeerShaker R. DakhilJudith O. HopkinsGary R. Morrow. (2018) Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. Journal of Clinical Oncology 36:32, pages 3231-3239.
Crossref
Crossref
Rebecca A. Harrison & Jeffrey S. Wefel. (2018) Neurocognitive Function in Adult Cancer Patients. Neurologic Clinics 36:3, pages 653-674.
Crossref
Crossref
Ali Amidi, S M Hadi Hosseini, Alexander Leemans, Shelli R Kesler, Mads Agerbæk, Lisa M Wu & Robert Zachariae. (2017) Changes in Brain Structural Networks and Cognitive Functions in Testicular Cancer Patients Receiving Cisplatin-Based Chemotherapy. JNCI: Journal of the National Cancer Institute 109:12.
Crossref
Crossref
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian & Jill B. Rich. (2017) Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neuroscience & Biobehavioral Reviews 83, pages 417-428.
Crossref
Crossref
Tracy D. Vannorsdall. (2017) Cognitive Changes Related to Cancer Therapy. Medical Clinics of North America 101:6, pages 1115-1134.
Crossref
Crossref
Erin O'Farrell, Andra Smith & Barbara Collins. (2017) Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?. Psycho-Oncology 26:10, pages 1667-1674.
Crossref
Crossref
Changyong Feng. (2017) Use Proper Indicators of Change in Neuropsychological Studies. MOJ Addiction Medicine & Therapy 3:5.
Crossref
Crossref
Ali Amidi, Mads Agerbæk, Lisa M. Wu, Anders D. Pedersen, Mimi Mehlsen, Cecilie R. Clausen, Ditte Demontis, Anders D. Børglum, Anja Harbøll & Robert Zachariae. (2016) Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging and Behavior 11:3, pages 769-783.
Crossref
Crossref
Jin-Hee Park, Yong Sik Jung, Ku Sang Kim & Sun Hyoung Bae. (2017) Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study. Supportive Care in Cancer 25:6, pages 1887-1896.
Crossref
Crossref
Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll & Sanne B. Schagen. (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA: A Cancer Journal for Clinicians 65:2, pages 123-138.
Crossref
Crossref
Jin-Hee ParkSun Hyoung BaeYong-Sik JungYoung-Mi Jung. (2015) Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer. Journal of Korean Academy of Nursing 45:1, pages 118.
Crossref
Crossref
Jeffrey S. Wefel, Damon J. Vidrine, Salma K. Marani, Richard J. Swartz, Tracy L. Veramonti, Christina A. Meyers, Harald J. Hoekstra, Josette E. H. M. Hoekstra-Weebers & Ellen R. Gritz. (2014) A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psycho-Oncology 23:6, pages 626-633.
Crossref
Crossref
Shelli R. Kesler, Christa Watson, Della Koovakkattu, Clement Lee, Ruth O’Hara, Misty L. Mahaffey & Jeffrey S. Wefel. (2013) Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging and Behavior 7:4, pages 501-510.
Crossref
Crossref
Shelli Kesler, S.M. Hadi Hosseini, Charles Heckler, Michelle Janelsins, Oxana Palesh, Karen Mustian & Gary Morrow. (2013) Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors. Clinical Breast Cancer 13:4, pages 299-306.
Crossref
Crossref
Erin O’Farrell, Joyce MacKenzie & Barbara Collins. (2013) Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”. Current Oncology Reports 15:3, pages 260-269.
Crossref
Crossref
Marie Østby-Deglum & Alv A. Dahl. (2013) Er cytostatika skadelig for hjernen?. Tidsskrift for Den norske legeforening 133:14, pages 1464-1465.
Crossref
Crossref
Jeffrey S. Wefel & Sanne B. Schagen. (2012) Chemotherapy-Related Cognitive Dysfunction. Current Neurology and Neuroscience Reports 12:3, pages 267-275.
Crossref
Crossref
K. Duff. (2012) Evidence-Based Indicators of Neuropsychological Change in the Individual Patient: Relevant Concepts and Methods. Archives of Clinical Neuropsychology 27:3, pages 248-261.
Crossref
Crossref
Vincent KoppelmansMonique M.B. BretelerWillem BoogerdCaroline SeynaeveChad GundySanne B. Schagen. (2012) Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy. Journal of Clinical Oncology 30:10, pages 1080-1086.
Crossref
Crossref
Mary Lou Galantino, Laurie Greene, Laura Daniels, Brandon Dooley, Laura Muscatello & Laura O'Donnell. (2012) Longitudinal Impact of Yoga on Chemotherapy-Related Cognitive Impairment and Quality of Life in Women with Early Stage Breast Cancer: A Case Series. EXPLORE 8:2, pages 127-135.
Crossref
Crossref
Lisa M. Sontag-Padilla, Lorah D. Dorn, Abbigail Tissot, Elizabeth J. Susman, Sue R. Beers & Susan R. Rose. (2012) Executive functioning, cortisol reactivity, and symptoms of psychopathology in girls with premature adrenarche. Development and Psychopathology 24:1, pages 211-223.
Crossref
Crossref
Jin-Hee ParkSun Hyoung Bae. (2012) A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer. Journal of Korean Academy of Nursing 42:5, pages 644.
Crossref
Crossref
Lea Ann Ouimet, Angela Stewart, Barbara Collins, Dwayne Schindler & Catherine Bielajew. (2011) Investigation of a neuropsychological screen for chemo-fog. Oncology Reviews 5:4, pages 205-213.
Crossref
Crossref
Jeffrey S Wefel, Janette Vardy, Tim Ahles & Sanne B Schagen. (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology 12:7, pages 703-708.
Crossref
Crossref
Michelle C. Janelsins, Sadhna Kohli, Supriya G. Mohile, Kenneth Usuki, Tim A. Ahles & Gary R. Morrow. (2011) An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status. Seminars in Oncology 38:3, pages 431-438.
Crossref
Crossref
T. Skaali, S.D. Fosså, S. Andersson, M. Cvancarova, C.W. Langberg, G. Lehne & A.A. Dahl. (2011) A prospective study of neuropsychological functioning in testicular cancer patients. Annals of Oncology 22:5, pages 1062-1070.
Crossref
Crossref
Tone Skaali, Sophie D. Fosså, Stein Andersson, Milada Cvancarova, Carl W. Langberg, Gustav Lehne & Alv A. Dahl. (2011) Self-reported cognitive problems in testicular cancer patients: Relation to neuropsychological performance, fatigue, and psychological distress. Journal of Psychosomatic Research 70:5, pages 403-410.
Crossref
Crossref
Tone Skaali, Sophie D. Fosså, Stein Andersson, Carl W. Langberg, Gustav Lehne & Alv A. Dahl. (2011) Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?. Psycho-Oncology 20:4, pages 369-377.
Crossref
Crossref
Jeffrey S. Wefel & Christina A. Meyers. (2010) Reply to Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 117:5, pages 1103-1104.
Crossref
Crossref
Margaret H. Cadden, Nancy S. Koven & Mitchell K. Ross. (2011) Neuroprotective Effects of Vitamin D in Multiple Sclerosis. Neuroscience and Medicine 02:03, pages 198-207.
Crossref
Crossref
Brenna C. McDonald, Susan K. Conroy, Tim A. Ahles, John D. West & Andrew J. Saykin. (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research and Treatment 123:3, pages 819-828.
Crossref
Crossref
Felice A. Tager, Paula S. McKinley, Freya R. Schnabel, Mahmoud El-Tamer, Ying Keun K. Cheung, Yixin Fang, Claire R. Golden, Margery E. Frosch, Ulya Habif, Margaret M. Mulligan, Ivy S. Chen & Dawn L. Hershman. (2009) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Research and Treatment 123:1, pages 25-34.
Crossref
Crossref
Jeffrey S. Wefel, Angele K. Saleeba, Aman U. Buzdar & Christina A. Meyers. (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:14, pages 3348-3356.
Crossref
Crossref
Jeanne Debess, Jens Østergaard Riis, Malene Cramer Engebjerg & Marianne Ewertz. (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Research and Treatment 121:1, pages 91-100.
Crossref
Crossref
Andrea Vodermaier. (2009) Breast Cancer Treatment and Cognitive Function: The Current State of Evidence, Underlying Mechanisms and Potential Treatments. Women's Health 5:5, pages 503-516.
Crossref
Crossref
Barbara Collins, Joyce Mackenzie, Angela Stewart, Catherine Bielajew & Shailendra Verma. (2008) Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Psycho-Oncology 18:8, pages 811-821.
Crossref
Crossref